Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT01313689 · COMPLETED
Trial details
- NCT number
- NCT01313689
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-14
- Primary completion
- 2014-03-18
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.